HANVON
At MWC2015, Hanvon (002362.SZ) gained enormous attention with its four core technologies, namely the Handwriting Recognition (HWR) Technology, the Internet of Vehicles Technology, the Electronic Signing, and the OCR Technology.
HWR
Hanvon is the first in the world to apply the HWR technology to the hand-held terminals. HWR as Hanvon's core technology supports a full recognition range, covering large character sets and multiple languages, and features low consumption and high-level code security. This technology has been widely applied in industries including finance, automotive and education.
Big Step for Internet of Vehicles
As a new human-vehicle-road technology, Internet of Vehicles has been gradually accepted. Intelligent and convenient, it will enjoy a continuous growth. Again Hanvon's HWR technology will be key to enabling the communication between the vehicle terminals and the drivers.
So far, auto manufacturers such as Volkswagen, Audi, GM and Lexus have adopted Hanvon's HWR technology in their vehicle terminals, which helps drivers give more accurate instructions.
Electronic Signing
Hanvon's electronic signing produces an output that is the same as "the original handwriting" and provides an experience like writing on real paper. Hanvon's electromagnetic pen is a patented technology. This pen gives users a natural writing experience with its unique "wireless passive" patent technology.
At present, Hanvon electronic signing technology is widely used in our daily life, such as banking, telecommunication, education, hospitals, hotels and so on.
Leading OCR Market
Hanvon's OCR technology is designed to recognize multi-language text, invoices, receipts, business cards, Passports/ID cards, bar codes and more. It can be applied in banks, financial institutions, taxation, telecommunication, transportation and many more. In addition, based on OCR Hanvon has developed a title recognition system in mathematics, physics, and chemistry to help online education websites recognize math problems submitted by users in the form of pictures and scan copies. Many well-known learning-machine manufacturers and online education institutions have established cooperation with Hanvon.
Hanvon expects to showcase its technologies and further strengthen its good reputations in the industry at this year's MWC. In the future, Hanvon will continue to focus on the mobile Internet field and bring more new technologies to the marketplace.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150304005331/en/
Contact:
Hanvon HWR / Hanvon OCR
Wei Lv, +86-10-82786830
lvwei@hanwang.com.cn
Niya
Fan, +86-10-82786832
fny@hanwang.com.cn
or
Hanvon
Electronic
Signing
Carol Zhang, +86-10-82786617
carol@hanwang.com.cn
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press release
TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy.After four years in development, the validated device and delivery strategy overcomes challenges of 3D formats and uses existing stereotactic components to support adoption through ease of delivery education. TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic re
Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press release
Valued at USD 1.3 billion, the project offers world-class amenities, including a signature Jacob & Co. ceiling art timepiece, the largest of its kind globally. Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Pentho
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release
Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release
Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma
Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release
Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum